Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kristina Busygina"'
Autor:
Andreas Lechner, Cornelia Then, Jochen Seissler, Uta Ferrari, Eleni Pappa, Kristina Busygina, Saori Harada, Hana Hermann
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 12, Iss 1 (2024)
Introduction Women with a history of gestational diabetes mellitus (GDM) are at high risk of developing type 2 diabetes, while the exact mechanisms underlying its pathophysiology are still unclear. We investigated the association of glucagon-like pep
Externí odkaz:
https://doaj.org/article/1113e2cb06814e0399d2dda1843f73e0
Autor:
Sylvère Störmann, Kristina Busygina, Ralph Hein-Rothweiler, Julius Steffen, Stefanie Förderreuther, Nora Salein, Matthias W. Angstwurm
Publikováno v:
Clinics and Practice, Vol 13, Iss 3, Pp 616-620 (2023)
We report the case of a 49-year-old male who suffered from a myocardial infarction with subsequent cardiac arrest. The emergency medical team began cardiopulmonary resuscitation, including defibrillation of ventricular fibrillation. Although a return
Externí odkaz:
https://doaj.org/article/6a4c58d7277b4986b13ed295359b5c37
Autor:
Elisa Waldmann, Liya Wu, Kristina Busygina, Julia Altenhofer, Kerstin Henze, Alexander Folwaczny, Klaus G. Parhofer
Publikováno v:
PLoS ONE, Vol 17, Iss 3 (2022)
Background and aims Familial dysbetalipoproteinemia (FDBL) is a rare inborn lipid disorder characterized by the formation of abnormal triglyceride- and cholesterol-rich lipoproteins (remnant particles). Patients with FDBL have a high risk for atheros
Externí odkaz:
https://doaj.org/article/360f58bffc12493b9f84ab21bee50732
Autor:
Eleni Pappa, Kristina Busygina, Saori Harada, Cornelia Then, Andreas Lechner, Uta Ferrari, Jochen Seißler
Publikováno v:
Diabetologie und Stoffwechsel.
Autor:
Elisa Waldmann, Liya Wu, Kristina Busygina, Julia Altenhofer, Kerstin Henze, Alexander Folwaczny, Klaus G. Parhofer
Publikováno v:
PloS one. 17(3)
Background and aims Familial dysbetalipoproteinemia (FDBL) is a rare inborn lipid disorder characterized by the formation of abnormal triglyceride- and cholesterol-rich lipoproteins (remnant particles). Patients with FDBL have a high risk for atheros
Autor:
Isabell Bernlochner, Christian Weber, Wolfgang Siess, Reinhard Lorenz, Kristina Busygina, Viola Denzinger
Publikováno v:
Thrombosis and Haemostasis, 119(8), 1212-1221. Georg Thieme Verlag
Bruton's tyrosine kinase (Btk) is essential for B cell differentiation and proliferation, but also platelets express Btk. Patients with X-linked agammaglobulinemia due to hereditary Btk deficiency do not show bleeding, but a mild bleeding tendency is
Autor:
Wolfgang Siess, Kristina Busygina, Reinhard Lorenz, Michael Spannagl, Viola Denzinger, Christian Weber, Janina Jamasbi, Isabell Pekrul
Publikováno v:
Thrombosis and Haemostasis, 119(3), 397-406. Georg Thieme Verlag
Ibrutinib and acalabrutinib are approved for B cell malignancies and novel Bruton's tyrosine kinase (Btk) inhibitors undergo clinical testing also in B cell-driven autoimmune disorders. Btk in platelets mediates platelet activation via glycoprotein (
Autor:
Kristina Busygina, Klaus G. Parhofer
Publikováno v:
MMW - Fortschritte der Medizin. 160:43-46
PCSK9-Inhibitoren stehen in Deutschland seit Herbst 2015 zur Therapie von Hypercholesterinamie und gemischter Dyslipidamie zur Verfugung. Aufgrund der hohen Therapiekosten stellt sich die Frage, fur welche Patienten sie in Frage kommen und wer sie ve
Autor:
Christian Weber, Kristina Busygina, Reinhard Lorenz, Till Seiler, Richard Brandl, Janina Jamasbi, Wolfgang Siess, Hans Deckmyn
Publikováno v:
Blood, 131(24), 2605-2616. The American Society of Hematology
Interaction of von Willebrand factor (VWF) with platelet glycoprotein lb (GPIb) and interaction of collagen with GPVI are essential for thrombus formation on ruptured or eroded atherosclerotic plaques (atherothrombosis). GPIb and GPVI signal through
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88eb4e6bdbf3a1b0df6d8005639751d9
https://cris.maastrichtuniversity.nl/en/publications/8d5ddf5b-54c5-42df-80e7-f776d6b75933
https://cris.maastrichtuniversity.nl/en/publications/8d5ddf5b-54c5-42df-80e7-f776d6b75933
Autor:
Kristina, Busygina, Klaus G, Parhofer
Publikováno v:
MMW Fortschritte der Medizin. 160(1)